Novartis Aktie
103,28
EUR
+1,50
EUR
+1,47
%
94,03
CHF
+1,30
CHF
+1,40
%
Werbung
Novartis Aktie Analyse
10.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
04.10.17 | Novartis Hold | Deutsche Bank AG | |
26.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.09.17 | Novartis kaufen | HSBC | |
07.09.17 | Novartis buy | HSBC | |
05.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
29.08.17 | Novartis Neutral | JP Morgan Chase & Co. | |
28.08.17 | Novartis Neutral | UBS AG | |
Werbung
|
|||
28.08.17 | Novartis buy | Kepler Cheuvreux | |
08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
04.08.17 | Novartis buy | Baader Bank | |
26.07.17 | Novartis overweight | Morgan Stanley | |
24.07.17 | Novartis buy | Jefferies & Company Inc. | |
20.07.17 | Novartis Neutral | UBS AG | |
19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.07.17 | Novartis Outperform | Bernstein Research | |
19.07.17 | Novartis buy | Société Générale Group S.A. (SG) | |
19.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
19.07.17 | Novartis Hold | Deutsche Bank AG | |
18.07.17 | Novartis Outperform | Bernstein Research | |
18.07.17 | Novartis Hold | S&P Capital IQ | |
18.07.17 | Novartis Neutral | UBS AG | |
17.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.07.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
10.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
07.07.17 | Novartis Hold | Deutsche Bank AG | |
05.07.17 | Novartis Underperform | Credit Suisse Group | |
04.07.17 | Novartis buy | Kepler Cheuvreux | |
23.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
23.06.17 | Novartis Equal weight | Barclays Capital | |
23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
23.06.17 | Novartis buy | Jefferies & Company Inc. | |
21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.06.17 | Novartis Hold | Deutsche Bank AG | |
21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
21.06.17 | Novartis buy | HSBC | |
16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
06.06.17 | Novartis Underweight | Morgan Stanley | |
02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Underweight | Barclays Capital | |
02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
01.06.17 | Novartis buy | Jefferies & Company Inc. | |
24.05.17 | Novartis Neutral | UBS AG | |
19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
12.05.17 | Novartis buy | Jefferies & Company Inc. | |
12.05.17 | Novartis Underweight | Morgan Stanley |
Werbung
Werbung